RespireRx Pharmaceuticals Inc. 4
4 · RespireRx Pharmaceuticals Inc. · Filed Apr 4, 2016
Insider Transaction Report
Form 4
WEINGARTEN ROBERT N
DirectorVice President and CFO
Transactions
- Award
Common Stock Options (to purchase shares of Common Stock)
2016-03-31+24,000,000→ 24,000,000 totalExercise: $0.02Exp: 2021-03-31→ Common Stock (24,000,000 underlying)
Holdings
- 10,000,000
Common Stock Options (to purchase shares of Common Stock)
Exercise: $0.02Exp: 2022-08-18→ Common Stock (10,000,000 underlying) - 15,000,000
Common Stock Options (to purchase shares of Common Stock)
Exercise: $0.03Exp: 2022-06-30→ Common Stock (15,000,000 underlying) - 5,000,000
Common Stock Options (to purchase shares of Common Stock)
Exercise: $0.05Exp: 2019-07-17→ Common Stock (5,000,000 underlying)
Footnotes (4)
- [F1]These Common Stock Options vest in four equal installments: 25 percent on March 31, 2016 (the grant date), 25 percent on June 30, 2016, 25 percent on September 30, 2016, and 25 percent on December 31, 2016.
- [F2]These Common Stock Options vest in four equal installments: 25 percent on December 31, 2015, 25 percent on March 31, 2016, 25 percent on June 30, 2016, and 25 percent on September 30, 2016.
- [F3]These Common Stock Options vest in three installments: 50 percent on June 30, 2015, 25 percent on September 30, 2015, and 25 percent on December 31, 2015.
- [F4]These Common Stock Options vested in three equal installments on July 17, 2014, September 30, 2014 and December 31, 2014, and are all currently vested and exercisable.